Aptorum Group Ltd Class A (APM)

NASDAQ
1.370
+0.050(+3.79%)
  • Volume:
    155,508
  • Day's Range:
    1.230 - 1.450
  • 52 wk Range:
    0.855 - 3.290

APM Overview

Prev. Close
1.3
Day's Range
1.23-1.45
Revenue
1.54M
Open
1.29
52 wk Range
0.855-3.29
EPS
-0.72
Volume
155,508
Market Cap
48.91M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
103,648
P/E Ratio
-
Beta
0.08
1-Year Change
-59.88%
Shares Outstanding
35,703,257
Next Earnings Date
-
What is your sentiment on Aptorum A?
or
Market is currently closed. Voting is open during market hours.

Aptorum Group Ltd Class A News

Aptorum Group Ltd Class A Company Profile

Aptorum Group Ltd Class A Company Profile

Employees
26

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A. The company is also developing ALS-2/3 for the treatment of gram+ve bacterial infections; RPIDD, a pathogen molecular diagnostic; NativusWell DOI (NLS-2), a dietary supplement; NLS-1 for the treatment of endometriosis; DLS-1+2 to treat NSCLC with mutation; DLS-3, an autoimmune small molecule; and CLS-1 for the treatment of obesity. Its pipeline products enable the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platforms for treatment of metabolic diseases. The company also focuses on therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. In addition, it operates a medical clinic. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyStrong BuyBuySell
Technical IndicatorsSellStrong BuyStrong BuyStrong BuyStrong Sell
SummaryNeutralStrong BuyStrong BuyStrong BuyStrong Sell